BURLINGTON, MA--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL) today announced that tivantinib and ARQ 087 will be included in seven presentations during the 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held from May 29-June 2, 2015 in Chicago, Illinois.
Help employers find you! Check out all the jobs and post your resume.
